Monthly Archives: September 2017

Weekly Roundup 9.29.17

Posted on September 29, 2017 by Mark Senak

Everyone has returned from vacations and extended vacations and are cramming to get business done before the year end string of holidays. There is been a good deal of activity this week, so let’s get right down to it.  FDA … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 9.29.17

Weekly Roundup 9.22.17

Posted on September 22, 2017 by Mark Senak

Today marks the beginning of autumn and the summer of 2017 is over. The first turning of trees has begun and leaves and acorns are dropping on lawns. The linens have left our closets and we are beginning to think … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 9.22.17

New FDA Directions – Part 3 – Opioids

Posted on September 21, 2017 by Mark Senak

In this third, and final installment on new directions for FDA under the watch of a new Commissioner, we turn to the issue of opioids. When Dr. Robert Califf was being considered for confirmation as FDA Commissioner he faced a … Continue reading →

Posted in FDA Policy | 1 Comment

Weekly Roundup 9.15.17

Posted on September 15, 2017 by Mark Senak

One season winds down, another offers hints of a beginning. I am afraid that both the regular Weekly Roundup as well as regular postings have lately been interrupted by some domestic issues that came up for me as well as … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 9.15.17

Weekly Roundup – 9.1.17

Posted on September 1, 2017 by Mark Senak

As hurricane season made itself felt this week, summer seems over in the east. Kids are back to school and this weekend summer whites and linens have their final appearance before next Memorial Day. Meanwhile it was a very busy … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 9.1.17